CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Dietary Modification - Vegetarian

Healing of Amyotrophic Lateral Sclerosis: A Case Report ?

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Healing of Amyotrophic Lateral Sclerosis - A Case Report.pdf)Healing of Amyotrophic Lateral Sclerosis - A Case Report.pdf[Healing of Amyotrophic Lateral Sclerosis - A Case Report]268 kB
facebook Share on Facebook
Abstract Title:

[Healing of Amyotrophic Lateral Sclerosis: A Case Report].

Abstract Source:

Complement Med Res. 2017 ;24(3):175-181. Epub 2017 Jun 12. PMID: 28641283

Abstract Author(s):

Inge Mangelsdorf, Harald Walach, Joachim Mutter

Article Affiliation:

Inge Mangelsdorf

Abstract:

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a devastating disease leading to death within 3-5 years in most cases. New approaches to treating this disease are needed. Here, we report a successful therapy.

CASE REPORT: In a 49-year-old male patient suffering from muscle weakness and fasciculations, progressive muscular atrophy, a variant of ALS, was diagnosed after extensive examinations ruling out other diseases. Due to supposed mercury exposure from residual amalgam, the patient's teeth were restored. Then, the patient received sodium 2,3-dimercaptopropanesulfate (DMPS; overall 86× 250 mg in 3 years) in combination with α-lipoic acid and followed by selenium. In addition, he took vitamins and micronutrients and kept a vegetarian diet. The excretion of metals was monitored in the urine. The success of the therapy was followed by scoring muscle weakness and fasciculations and finally by electromyography (EMG) of the affected muscles. First improvements occurred after the dental restorations. Two months after starting therapy with DMPS, the mercury level in the urine was increased (248.4 µg/g creatinine). After 1.5 years, EMG confirmed the absence of typical signs of ALS. In the course of 3 years, the patient recovered completely.

CONCLUSIONS: The therapy described here is a promising approach to treating some kinds of motor neuron disease and merits further evaluation in rigorous trials.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.